Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age.
Phase of Trial: Phase III
Latest Information Update: 13 Jul 2016
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics; Registrational
- Sponsors Sanofi; sanofi pasteur
- 02 Dec 2010 Additional location Canada identified as reported by ClinicalTrials.gov.
- 02 Dec 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 02 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.